Summary: The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain unknown. In this study, we carry out a genome-wide CRISPRi screen wherein we identify more than 600 genetic interactions that sustain eIF4E oncogenic activity. Our data show that eIF4E controls the translation of Tfeb, a key executer of the autophagy response. This autophagy survival response is triggered by mitochondrial proteotoxic stress, which allows cancer cell survival. Our screen also reveals a functional interaction between eIF4E ...
Genetic screening technologies with the CRISPR-Cas system have greatly expanded our ability to annot...
The eIF4E is an important eukaryotic translation initiation factor, because of its ability to bind c...
The eIF4E translation initiation factor has oncogenic properties and concordantly, the inhibitory eI...
The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protei...
Introduction: Cap-dependent mRNA translation is an essential for translation of key oncogenic protei...
University of Minnesota Ph.D. dissertation. April 2009. Major: Pharmacology. Advisor: Peter Bitterma...
BackgroundProtein synthesis is tightly regulated and alterations to translation are characteristic o...
BACKGROUND: Translation deregulation is an important mechanism that causes aberrant cell growth, pro...
SummaryeIF4E, the major cap-binding protein, has long been considered limiting for translating the m...
Large-scale genomic analyses of tumor cells have revealed many genetic alterations present in cancer...
Abnormal translate regulation is an important phenomenon in cancer initiation and progression. Eukar...
Elevated protein synthesis is an important feature of many cancer cells and often arises as a conseq...
none2The eukaryotic initiation factor 4E (eIF4E) is a key regulator of protein translation whose fun...
Genetically engineered mouse models are powerful tools for studying cancer genes and validating targ...
Although it was first observed nearly a century ago that transformed cells are marked by enlarged nu...
Genetic screening technologies with the CRISPR-Cas system have greatly expanded our ability to annot...
The eIF4E is an important eukaryotic translation initiation factor, because of its ability to bind c...
The eIF4E translation initiation factor has oncogenic properties and concordantly, the inhibitory eI...
The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protei...
Introduction: Cap-dependent mRNA translation is an essential for translation of key oncogenic protei...
University of Minnesota Ph.D. dissertation. April 2009. Major: Pharmacology. Advisor: Peter Bitterma...
BackgroundProtein synthesis is tightly regulated and alterations to translation are characteristic o...
BACKGROUND: Translation deregulation is an important mechanism that causes aberrant cell growth, pro...
SummaryeIF4E, the major cap-binding protein, has long been considered limiting for translating the m...
Large-scale genomic analyses of tumor cells have revealed many genetic alterations present in cancer...
Abnormal translate regulation is an important phenomenon in cancer initiation and progression. Eukar...
Elevated protein synthesis is an important feature of many cancer cells and often arises as a conseq...
none2The eukaryotic initiation factor 4E (eIF4E) is a key regulator of protein translation whose fun...
Genetically engineered mouse models are powerful tools for studying cancer genes and validating targ...
Although it was first observed nearly a century ago that transformed cells are marked by enlarged nu...
Genetic screening technologies with the CRISPR-Cas system have greatly expanded our ability to annot...
The eIF4E is an important eukaryotic translation initiation factor, because of its ability to bind c...
The eIF4E translation initiation factor has oncogenic properties and concordantly, the inhibitory eI...